Brand Name :Metfomix |
| Sitagliptin/ Metformin Extended release |
Category:Antidiabetic |
Active Ingredient:Sitagliptin(as Phosphate Monohydrate)/ Metformin HCL |
Dosage Form:Extended Release Tablet |
Administration:Oral |
License Holder:Koushan Pharmed/Iran |
Metfomix
Fexarella
20 December
Multi + Daily glow
25 December
Storage:Keep below 30 digree centigrade, protect from light and humide |
Indication:Mellitus Diabetes type 2 |
Packaging:60 Tablets per bottle in a box with patient leaflet |
Mechanism:Sitagliptin as dipeptidase 4 inhibitor and Metformin as a biguanide reduce the level of glucose by redusing the insuline resistancy |
Registration Code:Metfomix 50/500: 1790801118235238 |
